IceCure Medical Ltd (ICCM)
NASDAQ: ICCM
· Real-Time Price · USD
1.04
0.02 (1.96%)
At close: May 23, 2025, 3:59 PM
1.06
1.28%
After-hours: May 23, 2025, 04:16 PM EDT
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| China Revenue | 41K | 440K | 30K |
| China Revenue Growth | -90.68% | +1366.67% | n/a |
| India Revenue | 413K | 30K | 1.13M |
| India Revenue Growth | +1276.67% | -97.35% | n/a |
| Israel Revenue | 30K | 480K | 1.29M |
| Israel Revenue Growth | -93.75% | -62.82% | n/a |
| Japan Revenue | 481K | 1.51M | 604K |
| Japan Revenue Growth | -68.23% | +150.66% | n/a |
| Other Countries Member Revenue | 1.46M | 751K | n/a |
| Other Countries Member Revenue Growth | +93.87% | n/a | n/a |
| United States Revenue | 870K | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.25M | 2.66M | 2.17M | 1.95M | 2.21M | 1.9M | 2.44M | 2.17M | 2.16M | 2.03M | 2.41M | 2.46M | 2.17M | 1.66M | 1.22M | 988K | 657K | 778K | 671K | 671K | 625.49K | 621.37K | 528.87K | 519.59K | 553.53K | 392.31K | 385.83K | 404.25K | 366.13K | 306.06K | 330.68K | 318.48K | 318.55K | 288.37K | 462.46K | 611.78K | 632.22K | 733.01K | 684.18K | 781.8K |
| Selling, General, and Administrative Revenue Growth | +21.93% | +22.55% | +11.41% | -11.81% | +16.40% | -22.00% | +12.47% | +0.46% | +6.21% | -15.77% | -2.23% | +13.59% | +30.49% | +36.20% | +23.58% | +50.38% | -15.55% | +15.95% | 0.00% | +7.28% | +0.66% | +17.49% | +1.79% | -6.13% | +41.10% | +1.68% | -4.56% | +10.41% | +19.63% | -7.45% | +3.83% | -0.02% | +10.47% | -37.64% | -24.41% | -3.23% | -13.75% | +7.14% | -12.49% | n/a |
| Research and Development Revenue | 1.7M | 1.86M | 1.58M | 1.93M | 1.98M | 2.2M | 2.08M | 2.11M | 2.24M | 2.24M | 2.25M | 2.39M | 1.6M | 1.55M | 1.59M | 1.14M | 1.37M | 1M | 717K | 717K | 801.12K | 795.84K | 718.29K | 705.67K | 606.75K | 548.19K | 481.23K | 504.21K | 405.22K | 399.12K | 414.1K | 398.82K | 369.48K | 344.34K | 389.24K | 581.99K | 120.02K | 277.97K | 280.99K | 304.52K |
| Research and Development Revenue Growth | -9.12% | +17.67% | -18.03% | -2.45% | -9.90% | +5.82% | -1.52% | -5.63% | 0.00% | -0.80% | -5.81% | +49.53% | +3.56% | -2.52% | +38.64% | -16.50% | +36.32% | +40.17% | 0.00% | -10.50% | +0.66% | +10.80% | +1.79% | +16.30% | +10.68% | +13.91% | -4.56% | +24.43% | +1.53% | -3.62% | +3.83% | +7.94% | +7.30% | -11.54% | -33.12% | +384.92% | -56.82% | -1.07% | -7.73% | n/a |